2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide

C106H77N56O29S6- — CID 158864446

About 2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide

2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide (PubChem CID 158864446) has the molecular formula C106H77N56O29S6- and a molecular weight of 2791.55 g/mol. Its IUPAC name is 2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide.

Molecular Properties

• Compound Name: 2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide
• PubChem CID: 158864446
• Molecular Formula: C106H77N56O29S6-
• Molecular Weight: 2791.55 g/mol
• Exact Mass: 2789.46
• IUPAC Name: 2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide
• SMILES: Cc1nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(S(C)(=O)=O)cnn4-c4cccc(C(=O)O)c4)c3N)n2)c(N)c1/N=N/c1c(CS(=O)[O-])cnn1-c1cccc(C(=O)O)c1.O=C=O.O=C=O.O=C=O.O=C=O.O=S(=O)=O.[C-]#[N+]c1c(C)nn(-c2nc3ccc(S(=O)(=O)O)cc3s2)c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(C#N)c(C)nn4-c4nc5ccccc5s4)c3N)n2)c1N.[C-]#[N+]c1cnn(-c2cccc(C(=O)O)c2)c1/N=N/c1c(C)nn(-c2cc(-n3nc(C)c(/N=N/c4c(C#N)cnn4-c4cccc(C(=O)O)c4)c3N)nc(O)n2)c1N
• InChI: InChI=1S/C35H25N21O4S3.C34H24N18O5.C33H29N17O9S2.4CO2.O3S/c1-14-19(13-36)29(55(49-14)34-40-20-8-6-7-9-22(20)61-34)47-45-24-15(2)50-53(27(24)37)31-42-32(44-33(57)43-31)54-28(38)25(16(3)51-54)46-48-30-26(39-5)17(4)52-56(30)35-41-21-11-10-18(63(58,59)60)12-23(21)62-35;1-16-26(43-45-30-20(13-35)14-39-49(30)21-8-4-6-18(10-21)32(53)54)28(36)51(47-16)24-12-25(42-34(57)41-24)52-29(37)27(17(2)48-52)44-46-31-23(38-3)15-40-50(31)22-9-5-7-19(11-22)33(55)56;1-15-23(41-43-27-19(14-60(56)57)12-36-47(27)20-8-4-6-17(10-20)29(51)52)25(34)49(45-15)31-38-32(40-33(55)39-31)50-26(35)24(16(2)46-50)42-44-28-22(61(3,58)59)13-37-48(28)21-9-5-7-18(11-21)30(53)54;4*2-1-3;1-4(2)3/h6-12H,37-38H2,1-4H3,(H,58,59,60)(H,42,43,44,57);4-12,14-15H,36-37H2,1-2H3,(H,53,54)(H,55,56)(H,41,42,57);4-13H,14,34-35H2,1-3H3,(H,51,52)(H,53,54)(H,56,57)(H,38,39,40,55);;;;;/p-1/b47-45+,48-46+;45-43+,46-44+;43-41+,44-42+
• InChIKey: NIJYZYRQRSBPRK-WYDXINIESA-M
• XLogP: 11.57
• TPSA: 1229.78 Ų
• H-Bond Donors: 14
• H-Bond Acceptors: 80
• Rotatable Bonds: 32
• Heavy Atoms: 197
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2791.55
LogP ≤ 5	11.57
H-Bond Donors ≤ 5	14
H-Bond Acceptors ≤ 10	80

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'sulfinic_acid', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide?

The IUPAC name of 2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide (CID 158864446) is 2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide.

What is the SMILES notation for 2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide?

The canonical SMILES for 2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide is Cc1nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(S(C)(=O)=O)cnn4-c4cccc(C(=O)O)c4)c3N)n2)c(N)c1/N=N/c1c(CS(=O)[O-])cnn1-c1cccc(C(=O)O)c1.O=C=O.O=C=O.O=C=O.O=C=O.O=S(=O)=O.[C-]#[N+]c1c(C)nn(-c2nc3ccc(S(=O)(=O)O)cc3s2)c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(C#N)c(C)nn4-c4nc5ccccc5s4)c3N)n2)c1N.[C-]#[N+]c1cnn(-c2cccc(C(=O)O)c2)c1/N=N/c1c(C)nn(-c2cc(-n3nc(C)c(/N=N/c4c(C#N)cnn4-c4cccc(C(=O)O)c4)c3N)nc(O)n2)c1N.

What is the InChIKey of 2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide?

The InChIKey is NIJYZYRQRSBPRK-WYDXINIESA-M. The full InChI is InChI=1S/C35H25N21O4S3.C34H24N18O5.C33H29N17O9S2.4CO2.O3S/c1-14-19(13-36)29(55(49-14)34-40-20-8-6-7-9-22(20)61-34)47-45-24-15(2)50-53(27(24)37)31-42-32(44-33(57)43-31)54-28(38)25(16(3)51-54)46-48-30-26(39-5)17(4)52-56(30)35-41-21-11-10-18(63(58,59)60)12-23(21)62-35;1-16-26(43-45-30-20(13-35)14-39-49(30)21-8-4-6-18(10-21)32(53)54)28(36)51(47-16)24-12-25(42-34(57)41-24)52-29(37)27(17(2)48-52)44-46-31-23(38-3)15-40-50(31)22-9-5-7-19(11-22)33(55)56;1-15-23(41-43-27-19(14-60(56)57)12-36-47(27)20-8-4-6-17(10-20)29(51)52)25(34)49(45-15)31-38-32(40-33(55)39-31)50-26(35)24(16(2)46-50)42-44-28-22(61(3,58)59)13-37-48(28)21-9-5-7-18(11-21)30(53)54;4*2-1-3;1-4(2)3/h6-12H,37-38H2,1-4H3,(H,58,59,60)(H,42,43,44,57);4-12,14-15H,36-37H2,1-2H3,(H,53,54)(H,55,56)(H,41,42,57);4-13H,14,34-35H2,1-3H3,(H,51,52)(H,53,54)(H,56,57)(H,38,39,40,55);;;;;/p-1/b47-45+,48-46+;45-43+,46-44+;43-41+,44-42+;;;;;.

What are the key properties of 2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide?

2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide has a molecular weight of 2791.55 g/mol, XLogP of 11.57, 32 rotatable bonds, 14 hydrogen bond donors, and 80 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[5-[[5-amino-1-[4-[5-amino-4-[[1-(1,3-benzothiazol-2-yl)-4-cyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-isocyano-3-methylpyrazol-1-yl]-1,3-benzothiazole-6-sulfonic acid;3-[5-[[5-amino-1-[6-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-2-hydroxypyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]benzoic acid;[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-methylsulfonylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-(3-carboxyphenyl)pyrazol-4-yl]methanesulfinate;tetrakis(carbon dioxide);sulfur trioxide is sourced from PubChem (CID 158864446), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).